COMP <GO>
ACCL vs AMZN // OPERATING MARGIN
Acco Group Holdings Limited (Class A) (NASDAQ) VS. Amazon.com, Inc. (NASDAQ) • 15-METRIC TALLY: ACCL 2
— AMZN 4
■ METRIC PARITY
LAST: $2.59 (-0.38%) • MKT CAP: $36.1M
operating-margins
22.30%
LAST: $243.79 (-4.25%) • MKT CAP: $2.63T
operating-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ACCL VS. AMZN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ACCL | AMZN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 44.10% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | 17.61% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | 32.9x | 15.8x | +17.15 | AMZN | /valuation <GO> |
| Free Cash Flow Yield | 4.19% | -1.81% | +6.00 | ACCL | /fcf-yield <GO> |
| Operating Margin ACTIVE | 22.30% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 21.10% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 12.50% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 3.32 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 6/9 | +1.00 | ACCL | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.73% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 43.3 | 47.2 | -3.90 | AMZN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.46 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 29.7x | 22.8x | +6.95 | AMZN | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $36.1M | $2.63T | -$2.63T | AMZN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ACCL REV | AMZN REV | ACCL GROSS % | AMZN GROSS % | ACCL FCF | AMZN FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $0 | — | — | — | -$46.89B |
| FY 2025 | $4.9M | $0 | 44.1% | — | $1.5M | $10.56B |
| FY 2024 | $4.3M | $0 | 49.1% | — | $1.1M | $42.95B |
| FY 2023 | $3.7M | $0 | — | — | $742.0K | $16.92B |
| FY 2022 | — | $0 | — | — | — | -$26.32B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ACCL // BETA —
AMZN // BETA 1.46